Organization
Robert Flavell, MD, PhD
4 clinical trials
Clinical trial
Zirconium-89 Certolizumab PET Imaging in Patients With Rheumatoid ArthritisStatus: , Estimated PCD: 2025-03-31
Clinical trial
A First-in-Human, Pilot PET Imaging Study of 89Zr-DFO-YS5, an immunoPET Agent for Detecting CD46 Positive Malignancy in Men With Prostate CancerStatus: Recruiting, Estimated PCD: 2025-12-31
Clinical trial
A Pilot Study of Magnetic Resonance (MR) Imaging With Hyperpolarized Bicarbonate (13C) to Measure Tissue pH in Localized Prostate CancerStatus: Recruiting, Estimated PCD: 2025-12-31
Clinical trial
Pilot PET Imaging Study of [89Zr]DFO-YS5 for Detecting CD46 Positive Malignancy in Multiple MyelomaStatus: Recruiting, Estimated PCD: 2026-08-01